| Medical Condition | Progressive Pulmonary Fibrosis |
| Facility/Clinic | Accellacare – 1222 Medical Center Dr |
| Age | 18+ |
| Gender | Male & Female |
| Description | A placebo-controlled study of inhaled pirfenidone in progressive pulmonary fibrosis. |
| Enrollment | Open |
| Patient Commitment Duration | 1 year |
| Number of visits in study | 12 |
| Patient Compensation | $100 per visit |
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial.
Please call 910-799-5500 between the hours of 8am-5pm for general research questions.